Heterogeneous comparators and unadjusted differences may bias PRO comparisons of B/F/TAF: a letter to editor in response to “Health care provider- and patient-reported outcomes for bictegravir/emtricitabine/tenofovir alafenamide versus other antiretroviral regimens: an observational survey in the United States”
Abstract
Dear EditorI read with great interest the article by Colson and colleagues1, which reported that bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) was associated with higher health care pro...
Fields of Study & Subjects
HIV/AIDS drug development and treatment
HIV/AIDS Research and Interventions
HIV-related health complications and treatments
Publication details
- Journal / source
- Current Medical Research and Opinion
- Volume
- 42
- Issue
- 1
- Pages
- 149–150
- Publication date
- 2 January 2026
- Language
- EN